Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Trial Profile

The Effects of Opioid Taper on Opioid-Induced Hyperalgesia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 22 Mar 2018

At a glance

  • Drugs Buprenorphine/naloxone (Primary)
  • Indications Hyperalgesia; Opioid abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Mar 2018 Status changed from recruiting to discontinued.
    • 10 Jan 2018 Planned End Date changed from 1 Dec 2017 to 28 May 2018.
    • 10 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 28 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top